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Abstract
The effects of low-level ozone exposure (0.08 ppm) on pulmonary function in healthy young
adults are well known; however, much less is known about the inflammatory and
immunomodulatory effects of low-level ozone in the airways. Techniques such as induced sputum
and flow cytometry make it possible to examine airways inflammatory responses and changes in
immune cell surface phenotypes following low-level ozone exposure. The purpose of this study
was to determine if exposure to 0.08 parts per million ozone for 6.6 h induces inflammation and
modifies immune cell surface phenotypes in the airways of healthy adult subjects. Fifteen normal
volunteers underwent an established 0.08 part per million ozone exposure protocol to characterize
the effect of ozone on airways inflammation and immune cell surface phenotypes. Induced sputum
and flow cytometry were used to assess these endpoints 24 h before and 18 h after exposure. The
results showed that exposure to 0.08 ppm ozone for 6.6 h induced increased airway neutrophils,
monocytes, and dendritic cells and modified the expression of CD14, HLA-DR, CD80, and CD86
on monocytes 18 h following exposure. Exposure to 0.08 parts per million ozone is associated
with increased airways inflammation and promotion of antigen-presenting cell phenotypes 18
hours following exposure. These findings need to be replicated in a similar experiment that
includes a control air exposure.
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Introduction
In controlled exposure studies in which humans have been exposed for 2 h to O3 levels
ranging from 0.125 to 0.4 ppm, O3 has been reported to induce an immediate effect on lung
function that results in a transient neurogenic restrictive defect, as well as increased airway
hyperresponsiveness and inflammation, both of which may persist for >24 h (Schwela,
2000). Of these three main responses, pulmonary function has been extensively examined
whereas inflammation, particularly at concentration levels at or near the 8-h-daily average
National Ambient Air Quality Standard (NAAQS) of 0.08 ppm, has been the least well
examined. Consequently, this paper will not address changes in pulmonary function.
The last and only study to examine the inflammatory effects of low-level O3 exposure (0.08
ppm) for 6.6 h in healthy adults was performed by our group in 1991 where bronchoalveolar
lavage (BAL) was used to measure cellular and biochemical changes 24 h following
exposure (Devlin et al., 1991). We reported that exposure to 0.08 ppm O3 resulted in
significant increases in polymormonuclear neutrophils (PMNs), prostaglandin E2 (PGE2),
lactate dehydrogenase (LDH), interleukin (IL)-6, α1-antitrypsin, and decreased phagocytosis
via the complement receptor. Since that study, O3 has been recognized as having a
preferential absorption in the large central airways during exercise (Hu et al., 1994), a region
not sampled by the pooled fraction of the BAL fluid reported in the 1991 study. The large
airways, however, are a region of the lung from which induced sputum samples derive
(Alexis et al., 2001) and hence provide a more sensitive method of characterizing the
inflammatory response at low O3 concentrations. Recently, we reported in healthy subjects
that sputum cell surface phenotypes are modified following a 2-h exposure to 0.4 ppm O3
(Alexis et al., 2004, 2008b; Lay et al., 2007). It is unknown whether these effects are
occurring in the airways at O3 concentrations at or near the NAAQS level of 0.08 ppm.
The present study is an extension of our earlier report in two important ways. First, we have
used induced sputum to allow selective assessment of the central airways inflammatory
response, and second, employed the technique of flow cytometry to measure whether 0.08
ppm O3 can modify cell surface phenotypes that are associated with innate and acquired
immune responses. These cell surface receptors include mCD14, CD80, CD86, and human
leukocyte antigen (HLA)-DR. Flow cytometry will also be used to better characterize airway
inflammatory cell populations such as mature and immature macrophages, newly recruited
and longer resident neutrophils, monocytes, and dendritic cells (Alexis et al., 2005; 2000;
Lay et al., 2007).
There is now notable interest in the public health effect of low-level O3 exposure (≤0.08
ppm). As a result, we are undertaking a series of studies aimed at elucidating the impact of
low-level O3 exposure on cellular and biochemical markers of airways inflammation and
markers of immune modulation. This study is the first such study and serves as an initial
hypothesis-generating assessment of low-level O3 exposure, since it details findings in
healthy volunteers without a formal control exposure to filtered air. Follow-up studies will
expand on the results reported here and include a control exposure to filtered air.
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Volunteer recruitment and inclusion criteria
This protocol was reviewed and approved by the University of North Carolina Committee
on the Rights of Human Subjects (Institutional Review Board) and all subjects provided
written informed consent prior to participation. All subjects underwent a physical
examination, a routine blood panel with complete blood count (CBC) and differential, serum
electrolytes, glucose, and liver enzymes. Female subjects had to have a negative urine
pregnancy test prior to challenge and all volunteers were required to be free of chronic
cardiovascular or respiratory illness, and be free of acute respiratory illness within 4 weeks
of O3 challenge. All subjects had forced expiratory volume in one second (FEV1) and forced
vital capacity (FVC) ≥ 80% predicted and FEV1/FVC ≥ 80% predicted normal for height
and age, and were nonsmokers with no smoking history. All subjects were screened for their
ability to provide an adequate inducedsputum sample during their training session as well as
establish their target minute ventilation for the exercise component of the exposure.
Sputum collection
Sputum was obtained in the morning at least 24 h before exposure (baseline sample) and in
the morning 18 h following completion of the 6.6-h exposure to 0.08 ppm O3, using
techniques previously described (Alexis et al., 2001, 2000). In brief, three 7-min inhalation
periods of nebulized hypertonic saline (3%, 4%, 5%) (DeVilbiss UltraNeb 99 ultrasonic
nebulizer) were followed by careful expectoration of sputum into a sterile specimen cup. A
cell-enriched “select” sample was obtained by manually selecting plug material from the
surrounding clear saliva fluid. The total selected sample was then treated with a dilute
(0.1%) solution of dithiothrietol (DTT; Sputolysin; Calbiochem, San Diego, CA) in
Dulbecco’s phosphate-buffered saline (DPBS) to digest mucus. Following filtration and
centrifugation (500 × g, for 10 min), aliquots of sputum supernatant were immediately
frozen and stored at −80°C and the cell pellet was suspended in a small volume (0.5–1 ml)
of Hanks balanced salt solution (HBSS). Cell viability (trypan blue exclusion) and total cell
counts were assessed in a Neubauer hemacytometer and differential cell counts were
performed on cytocentrifuged cells that were adjusted to a concentration of 1 × 106 cells//ml
and stained with a modified Wright’s stain, (Hema-Stain −3; Fisher Scientific). A portion of
the remaining cells were immediately used for flow-cytometric assays.
Sputum sample analysis
Sputum samples were assessed for total and differential cell counts, with differential counts
being achieved by both microscopic examination and flow-cytometric identification on
carefully gated populations of neutrophils, macrophages, and monocytes based on positive
expression of CD45 with CD16, HLA-DR, and CD14, respectively. Cell counts were
expressed as cells/mg sputum. Expression of selected cell surface molecules on sputum
leukocytes was quantified via multicolor flow cytometry (FCM) using a BD LSR-II flow
cytometer and have been described previously (Alexis et al., 2006) (BD Immunocytometry
Systems, San Jose, CA). These included molecules associated with antigen presentation and
specific immunity (CD80/B7.1, CD86/B7.2, HLA-DR/MHC-II, CD11c), as well as innate
immune function (CD11b/CR3, CD14/LPS receptor, CD16/FcγRIII, CD64/FcγRI). Sputum
leukocytes were differentiated from cellular debris, bacteria, yeast, and squamous and
bronchial epithelial cells by initially gating on CD45+ cells and setting appropriate filter
levels (200) based on light scatter properties.
Leukocyte populations were differentiated by various specific gating strategies based on a
combination of light-scattering properties and the differential expression of CD45 (pan-
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leukocyte marker) and select surface lineage markers. Dendritic cells (DCs) were identified
as lineage-dim/neg/HLA-DRhigh cells, the vast majority being CD11c(+).
Up- or down-regulation of specific surface molecules was quantified as a change in the
mean fluorescent intensity (MFI) of the gated population. Fluorochrome-labeled antibodies
were obtained from BD Biosciences (CD11b-PE-CY5, CD11c-APC, CD45-APC-Cy7,
CD206-APC, HLA-DR-PerCP, Lineage Coctail-1 FITC) or Beckman-Coulter (CD14-APC,
CD80-FITC, CD86-PE). Appropriate, nonspecific, labeled isotypic control antibodies were
also obtained from these sources. Expression of CD11b, CD14, CD16, CD80, CD86, and
HLA-DR was quantified.
Sputum supernatants were also assessed for cytokine concentration using multiplex
technology (Meso ScaleDiscovery/MSD, Gaitherburg, MD). Each sample was analyzed
with the Human MIP-1 alpha Ultra Sensitive Kit (lot no. K0031370) and the Human TH1/
TH2 10-Plex Ultra Sensitive Kit (lot no. K0031431). All supernatant samples were diluted
1:4 and had a final dithiothreitol (DTT) concentration of <1 mM where no deleterious
effects have been observed using the MSD platform (Bafadhel et al., 2007).
Ozone exposure and testing protocol
The O3 exposures were conducted in an O3 exposure chamber at the US Environmental
Protection Agency (EPA) Human Studies Facility on the campus of the University of North
Carolina, Chapel Hill, NC (Koren et al., 1989). Volunteers underwent moderate intermittent
exercise during a 6.6-h exposure to 0.08 ppm O3. Because repeated experimental exposure
to O3 has been shown to result in adaptation of the lung function response to O3 (Folinsbee
et al., 1994; Gong et al., 1997) and to modify airway inflammatory responsiveness
(Arjomandi et al., 2005; Christian et al., 1998; Jorres et al., 2000) we limited our study to
October through March, outside of the O3 monitoring season in North Carolina. This was
done to avoid any potential masking of the effect of low-level experimental O3 exposure due
to potential adaptation from repeated daily exposure to elevated ambient air O3.
Each exercise session consisted of a 50-min exercise at a level of approximately 20 L/min/
m2 body surface area (BSA) in minute ventilation followed by a 10-min rest, which was
repeated six times, with exercise alternating between a treadmill and bicycle ergometer.
Minute ventilation was assessed during the first two exercise sessions and settings of the
treadmill or bicycle were adjusted to bring the minute ventilation to within ±2 L/min of the
subject’s target value. Following the third exercise session, each subject was allowed an
additional 35-min break to eat lunch.
Statistical analysis
Our a priori primary hypothesis is that airway inflammation will be increased following 6.6
h of exposure to 0.08 ppm O3. Comparisons of baseline neutrophils, monocytes,
macrophages, and dendritic cells expressed as cells/mg sputum to that observed the morning
after O3 exposure were conducted using the Wilcoxon procedure for paired samples. To test
differences between baseline and post-O3 values of expression of cell surface proteins on
monocytes and macrophages, as well as differences in mediators in fluid phase supernatants
of sputum samples, the Wilcoxon procedure for paired samples was used. Correlation
analysis was performed using Pearsons product correlation coefficient (R). Significance was
set at α = .05 for two-tailed t test.
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Demographics and safety measures
Fifteen healthy volunteers were recruited into this protocol. Seven (six Caucasian and one
African American) were male and eight (six Caucasian and two African American) were
female. The mean age was 24 ± 1 years (range 19–35 years). There were no adverse events
associated with the exposures.
Effect of 0.08 ppm ozone on airway inflammatory cells
Individual subject responses for neutrophils (PMNs), monocytes, macrophages, and
dendritic cells (DCs) are shown in Figure 1. Mean ± SEM baseline airway neutrophilia was
349 ± 109 PMNs/mg sputum and was significantly increased to 895 ± 217 PMNs/mg
sputum the morning following O3 challenge (p = .001). Mean ± SEM baseline airway
monocytes were 68 ± 12 monocytes/mg sputum and were increased to 128 ± 36 monocytes/
mg sputum the morning following O3 challenge (p = .06). Mean ± SEM baseline dendritic
cells were 6.0 ± 2 DCs/mg sputum and significantly increased to 11 ± 5 DCs/mg sputum
following O3 challenge (p = .03), whereas mean ± SEM baseline airway macrophage counts
were 355 ± 67 macrophages/mg sputum and decreased slightly to 337 ± 81 macrophages/mg
sputum the morning following O3 challenge.
Effect of 0.08 ppm ozone on airway cell surface phenotypes
Expression (MFI) of CD14, CD86, and HLA-DR was significantly increased, and CD80
significantly decreased on monocytes recovered after O3 challenge (Figure 2). CD11b,
CD16, and CD64 expression on airway monocytes were not significantly affected by O3
challenge. On airway macrophages, expression of CD14 was significantly increased and
CD80 and HLA-DR significantly decreased after O3 challenge (Figure 3). Like monocytes,
CD11b, CD16, and CD64 expression on airway macrophages was not significantly altered
after O3 challenge. We observed no significant changes in any of the cell surface phenotypes
on neutrophils or dendritic cells following O3 exposure (data not shown).
Airway cytokines
We also examined sputum supernatants for a number of proinflammatory cytokines
(interferon-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, macrophage
inflammatory protein 1α [MIP1α], and tumor necrosis factor α [TNFα]). Of these, we
observed significant increases in IL-6, IL-8, IL-12p70, and TNFα the morning after
challenge compared to baseline challenge. These results are depicted in Figure 4. Of these
cytokines, correlation analysis revealed that IL-12p70 was significantly associated with the
increase in dendritic cells following O3 exposure (R = .58, p = .03).
Discussion and conclusions
To our knowledge, this is the only report using flow cytometry to quantify changes in
airway cell populations and immunophenotype characteristics following exposure of humans
to 0.08 ppm O3. We confirmed our earlier study by showing that this near-ambient level of
ozone caused pulmonary inflammation, as evidenced by a significant increase in airway
neutrophils and a number of proinflammatory cytokines. In addition, we show here that O3
exposure also caused an influx of monocytes and dendritic cells, and that airway monocytes
expressed higher levels of CD14, CD80, CD86, and HLA-DR compared to those collected
at baseline. These results suggest that in addition to recruiting of granulocytes to the airway,
O3 exposure also results in an influx of immunomodulatory cells with modified cell surface
phenotypes. It is noteworthy that we are finding ozone-induced inflammation near the
current National Ambient Air Quality Standard of 0.08 ppm O3 averaged over 8 h.
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When we compare the results of the present study regarding neutrophil influx following 0.08
ppm O3 exposure to those from our earlier study in 1991 (Devlin et al., 1991), we find a
much greater degree of neutrophilic inflammation. This may be due in part to sputum
sampling central, rather than distal, airway samples (Alexis et al., 2001). Arjomandi et al.
(2005) also reported increased baseline neutrophilia in induced sputum of subjects exposed
to O3 with poor correlation to more distal alveolar samples. Although inflammation in the
distal airways has been observed following O3 exposure by our group and others (Devlin et
al., 1991; Joad et al., 2006), data here suggest that sampling the proximal airways may be a
more sensitive approach for assaying pollutant-induced inflammation, at least in the case of
O3. In addition, identification and quantification of inflammatory cell populations by flow
cytometry enhances the accuracy of leukocyte evaluation by reducing biases in cytospin
counting, as reported by Hodge et al. (2004). In that study, Hodge and colleagues (2004)
compared flow-cytometric versus manual counting of BAL cells in chronic obstructive
pulmonary disease (COPD) patients and reported a tendency by cytospins to overestimate
the percentage of macrophages by 5.9%.
One important limitation in this study, as compared to previous ozone studies, was the
absence of data in which subjects were exposed to both clean air (sham exposure) and O3 on
separate occasions, in order to control for the potential effect of exercise on airways
inflammation. We contend that for this initial hypothesis generation study, a strict
requirement to include a sham exposure was not necessary. In our previous O3 studies where
we employed sham exposures and compared cellularity of sputum (and bronchial wash) at
baseline (prechallenge) versus clean air (with exercise), we found no difference between the
clean air and preexposure baseline samples (Lay et al., 2007; Peden et al., 1997). We further
note that in the bronchial wash study noted above, the exposure duration and exercise
protocol were almost identical to the one used here, and employed the same postexposure
sampling time as this study. In addition, whatever potential effect exercise may have had on
our inflammatory endpoints, it would have been minimal and likely resolved 18 h
postexposure. However, despite these data, we note that the absence of an air exposure in
this study places limitations on the interpretation of the results reported here. Another
limitation to note in our study was potential technician bias in processing the pre- and
postexposure sputum samples because they were not formally blinded to this component.
We note, however, that certain measures were in place to help reduce or avoid this potential
bias, such as exposure day information was not present on the sample containers and pre-
and postexposure samples were generally collected at the same time of day.
Although the ability of O3 to induce airway neutrophilia is well known, the effect of O3 on
other inflammatory or immunomodulatory cells in the airway has been less well studied. We
previously reported that 0.4 ppm O3 causes increases in airway monocytes, with increased
expression of CD11b, CD14, CD86, and HLA-DR (Lay et al., 2007). This study extends
these findings by demonstrating that even very low concentrations of O3 can alter monocyte
phenotype. We have made similar observations in healthy and allergic volunteers in airway
sputum recovered after inhalation challenge with 20,000 endotoxin units (Alexis et al., 2005,
2008a). These surface markers are essential to modulating key elements of both innate and
acquired immunity, and may play a role in antigen presentation. Although we did not
observe changes in expression of cell surface proteins on dendritic cells after O3, we did see
O3-induced changes in IL-12p70 levels that correlated with increases in dendritic cells found
in airway sputum after O3 exposure. IL-12p70 is secreted by activated dendritic cells and
plays a significant role in antigen presentation and immune response (Trinchieri et al.,
2007). Furthermore, we report increased levels of proinflammatory cytokines IL-8, IL-6, and
TNFα, cytokines that are associated with an inflammatory cellular milieu, particularly
neutrophils in the case of IL-8 and monocytes and macrophages in the case of IL-6 and
TNFα. The absence of any significant change in the other cytokines measured in this study
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may reflect their lack of a specific association with neutrophilic or monocyte-induced
inflammation, both of which were present at 18 h postexposure. On the other hand, it may
reflect a shorter time course of activation for these cytokines such that their levels returned
to baseline values by 18 h postexposure.
Taken together, these observations support the idea that inhaled environmental toxicants
may promote adverse health events by enhancing the numbers of immunoregulatory cells
such as monocytes and dendritic cells present in the airway. Furthermore, in the case of
monocytes, there appears to be a phenotype bias toward antigen presentation. We
hypothesize that recruitment of such cells to the airway would enhance innate or acquired
immune responses to biological material associated with particulate matter, bioaerosols, or
domestic environments that contain allergens.
Consistent with our hypothesis that O3-induced influx of immunomodulatory cells to the
airway modulates the adverse health effects associated with this pollutant are observations
by our group and others that experimental O3 exposure enhances immediate and late-phase
airway response to allergens (Bernstein et al., 2004; Peden et al., 2005). Koike and
colleagues (2004) have shown that antigen-presenting cell activity of cells recovered from
the respiratory tract of rodents is enhanced after O3 challenge. O3 has also been shown to
enhance sensitization of infant rhesus monkeys to mite allergen, a process that clearly
involves antigen presentation (Joad et al., 2006).
In this report we describe the influx of neutrophils, monocytes, and dendritic cells and their
modulated surface phenotypes to the airways of healthy human volunteers the morning after
exposure to 0.08 ppm O3, a level frequently encountered in most metropolitan areas in the
United States. We hypothesize that these immunoinflammatory changes induce direct injury
to the airway, and markedly increase responsiveness to other pollutants, bioaerosols, and
allergens in normal healthy persons and likely in those with asthma. Enhanced antigen
presentation capability will induce exaggerated T-cell responses where in the case of atopic
asthma will promote Th-2 inflammation in the airway. In considering the public health
implications of exposure to ambient air levels of O3, it will be important to fully understand
the effect of this pollutant on inflammatory and immunomodulatory cells in the airway.
Finally, the results reported in this study need to be confirmed in a subsequent study
employing a control exposure.
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Individual subject inflammatory cell responses (cells/mg sputum) following ozone exposure
(closed square) compared to baseline (open circle). Neutrophils (p = .001, upper left panel),
macrophages (p > .05, upper right panel), monocytes (p = .06, lower left panel), and
dendritic cells (p = .03, lower right panel).
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Expression (MFI) of sputum monocyte surface proteins on individual subjects following
ozone exposure compared to baseline. CD14 (p = .01, upper left panel), CD80 (p = .01,
upper right panel), CD86 (p = .01, lower left panel), and HLA-DR (p = .001, lower right
panel).
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Expression (MFI) of sputum macrophage surface proteins on individual subjects following
ozone exposure compared to baseline. CD14 (p = .04, upper left panel), CD80 (p = .01,
upper right panel), CD86 (p = .06, lower left panel), and HLA-DR (p = .02, lower right
panel).
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Cytokine values (pg/ml) on individual subjects following ozone exposure compared to
baseline. IL-6 (p = .02, upper left panel), IL-8 (p = .05, upper right panel), IL-12p70 (p = .
004, lower left panel), and TNFα (p = .03, lower right panel).
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